Company Overview and News
Lithium spot prices in China fall slightly, and global contract prices rise - The price gap is now closed.
LIT CXO SAV LAXXF LIACF CYDVF PFFOF WML POR ABEPF SQM MLNLF KOD AVLNF KDR SYA STLHF WMLLF LNRDY ADV ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY LACDF MIN LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF LAC PLS NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF CYP MALRF ORE AVZ AJM
Lithium China spot prices down again, as global contract prices rise. The gap has now narrowed.
LIT BCN PIO PILBF LTHHF CXO SAV 500008 BNPQY LAXXF LIACF AGY BAR NMT ARJQY PLLLY RDRUY AZZVF MS WML SQM MLNLF AIS.H KDR SYA STLHF WMLLF LNRDY NGZ AMVMF BNPZY LMMFF GXY LRS MNIKF ILHMF AMLM ALB GFI.WI DMNXF MALRY BGS LACDF EEYMF PIONF MIN NMKEF ARYMF AMARAJABAT ILC GALXF MGXMF LSSCF ALTAF DJIFF NMX EMH PSC CRECF OROCF GFIOF ERPNF LAC PLS BNPQF BCN DJI RRSSF PDDTF NTTHF GFI MALRF ORE AVZ AJM BCRMF
Welcome to the fourth edition of Gold Panda's weekly series of articles covering the best drill interception in the metals mining sector. My first three articles from the series can be read here, here and here.
WLBMF AZZVF AVZ TECK
2018-08-27 seekingalpha - 1
Lithium market news - China’s lithium price decline is not the full picture to an industry surging.
LIT CXO SAV LAXXF LIACF AGY PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H KDR SYA STLHF WMLLF LNRDY ADV ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY MIN ARYMF LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF ERPNF PLS GSC NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF MALRF ORE AVZ AJM
Lithium market news - The Benchmark Minerals megafactory tracker is now at 41 in the pipeline.
LIT BCN PILBF LTHHF CXO SAV LAXXF LIACF AGY NMT PLLLY RDRUY AZZVF MS WML SQM MLNLF AIS.H KDR SYA STLHF WMLLF LNRDY NGZ AMVMF LMMFF GXY TAW LRS MNIKF ILHMF AMLM ALB DMNXF MALRY BGS LACDF EEYMF MIN NMKEF ARYMF ILC GALXF MGXMF LSSCF ALTAF DJIFF NMX EMH PSC CRECF OROCF ERPNF LAC PLS BCN TWNAF DJI RRSSF PDDTF NTTHF TSLA MALRF ORE AVZ AJM BCRMF
AVZ Minerals has released a maiden mineral resource for the Manono project in the Democratic Republic of Congo (DRC), establishing the site as a major site for lithium production.
2018-07-26 seekingalpha - 1
Lithium spot and contract price news - China spot prices slightly down in July, global contract prices remain strong.
LIT CXO SAV LAXXF LIACF PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H SYA STLHF WMLLF LNRDY ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF MALRY MIN LKE DDXFF MGXMF PLUUF DJIFF PSC EMH CRECF ERPNF PLS GSC NNO LTMCF DJI PDDTF NTTHF NNOMF AVLIF BCLMF MALRF ORE AVZ AJM
Lithium market - Goldman: Concerns about a wave of supply of the electric car battery material from new mines are unfounded. The selloff in companies tied to lithium is overdone.
LIT BCN PILBF LTHHF CXO SAV LAXXF LIACF AGY NMT KSN PLLLY RDRUY AZZVF WML MLNLF AIS.H KDR DFS SYA STLHF WMLLF LNRDY NGZ LMMFF GXY TAW LRS MNIKF ILHMF AMLM DMNXF MALRY BGS LACDF EEYMF MIN NMKEF ARYMF ILC GALXF MGXMF LSSCF ALTAF DJIFF NMX EMH PSC CRECF OROCF ERPNF LAC PLS FTI.WI FMC BCN TWNAF DJI RRSSF PDDTF NTTHF AVLIF MALRF ORE AVZ AJM BCRMF
Hipo Resources Ltd (ASX:HIP) has successfully completed technical and legal due diligence at its Kamola lithium project in the Democratic Republic of Congo (DRC) and will move forward with a 60% farm-in to the project.
CWMZF CWM AVZ
2018-07-03 seekingalpha - 2
This article was first published on Trend Investing on May 4; therefore all data is as of that date.
URA CLA CCZ SRHYY KBGCF CYDVF LMRMF PCRCF PLM.RT HNCKF SNNAF ZEYYF WML POR SQM AVLNF BXTMF AIS.H POM AYR KBBRF ABE FTMDF MNIKF GBLEF GLCNF TON NMKEF POS DNI MGXMF DJIFF GME CRECF AQR LMR NGPHF CDNMD LEMIF CDNMF GLK WWR AEOMF KATFF KNL NTTHF ECORF URI CNJ TSLA FCSMF HLPCF CUC AJM WSCRF GRXXF SIE TNTMF CXO SAV HAV LIACF MUM URLNF NI HIG URRE PFFOF TAKRF ABEPF PSDNF STLHF SYA GPHOF LLG APMFD WMLLF APMFF NSRC CYLYF NGZ RNX.WT GXY KAT PLU VNCKF AMLM CSSQF XTM AVL ALB FMS LACDF HBNRF CZI ZENYF AUZ RNX PLUUF RNKLF DMNKF NMX SYR GLKIF EMH OROCF MSMGD LAC MSMGF PLS FT CARCF FTI.WI FMC ZEN USCFF DJI SYAAF PDDTF PLM AVLIF CYP NSRCF MGPHF MCCBF LNZCF ORE AVZ
Two local mining companies have been forced to provide clarifications to the ASX this morning, with Flinders Mines responding to a leaked presentation from BBI Group, while lithium-focused AVZ Minerals told investors to ignore a Twitter post from one of its strategic advisers.
FLNDF FMS AVZ
AVZ Minerals Ltd (ASX:AVZ) has recorded the largest lithium pegmatite intersection to date from its Manono Lithium Project in the Democratic Republic of Congo.
AVZ Minerals has achieved a record 341.62m intersection from the Manono lithium project in the Democratic Republic of Congo (DRC).
2018-06-27 seekingalpha - 1
Lithium market news: Joe Lowry significantly raised his new lithium demand forecast to ~800K MT LCE in 2025. Indian State-owned firms mandated to acquire overseas lithium and cobalt.
NI LIT CXO SAV LAXXF LIACF CYDVF AGY PFFOF WML POR ABEPF SQM MLNLF AVLNF AIS.H KDR SYA STLHF WMLLF LNRDY HMGLF PEMIF ABE NGZ LMMFF GXY LRS MNIKF PLU HNR AMLM 9984 AVL ALB DMNXF MALRY EEYMF SFTBF MIN NMKEF ARYMF LKE DDXFF MGXMF PLUUF DJIFF NMX PSC EMH CRECF ERPNF SFTBY PLS NNO DJI PDDTF NTTHF NNOMF CYP MALRF ORE AVZ AJM
19h - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...